Rosavin, an orally bioactive phenylpropanoid from Rhodiola rosea L. (RRL), is an adaptogen that enhances the body's response to environmental stress. It significantly influences bone tissue metabolism by inhibiting osteoclastogenesis and promoting osteoblast differentiation. Rosavin also demonstrates antidepressant, adaptogenic, and anxiolytic effects in mouse models. Additionally, it improves survival by reducing intestinal damage in irradiated rats and protects against Ischemia-reperfusion (I/R)-induced cerebral injury in vivo.
- Enhances the body's response to environmental stress.
- Influences bone tissue metabolism by inhibiting osteoclastogenesis and promoting osteoblast differentiation.
- Demonstrates antidepressant, adaptogenic, and anxiolytic effects.
- Improves survival, reducing intestinal damage in irradiated rats.
- Protects against Ischemia-reperfusion (I/R)-induced cerebral injury in vivo.